Agilon HealthAGL +4.02%74 Buyback Yield % is 0.16 as of Jul. 09, 2026. GuruFocus rates AGL with a GF Score™ of 74/100 and a GF Value™ of $94.38 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 276 Healthcare Providers & Services companies, Agilon Health ranks better than 63.04% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Agilon Health's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Agilon Health's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agilon Health Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Agilon Health's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Agilon Health's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agilon Health (AGL) has a Buyback Yield % of 0.16 as of Jul. 09, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Agilon Health and its competitors. According to the industry distribution chart, Agilon Health ranks #102 out of 276 companies in the Healthcare Providers & Services industry, placing it in the top 37%.
Is Agilon Health's Buyback Yield % too high?
Agilon Health's current Buyback Yield % is 0.16. Based on the distribution chart, Agilon Health ranks #102 out of 276 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Agilon Health has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Agilon Health's Buyback Yield % compare to MD and SEM?
According to the Healthcare Providers & Services industry distribution chart, Agilon Health ranks #102 out of 276 companies for Buyback Yield %. This puts Agilon Health in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Agilon Health and its competitors. Agilon Health's current Buyback Yield % is 0.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilon Health stock overvalued right now?
Based on GuruFocus' analysis, Agilon Health (AGL) is currently considered Modestly Overvalued. The stock's GF Value™ is $94.38, compared to a current price of $111.79 — trading 18.4% above its estimated fair value. The current Buyback Yield % is 0.16. Agilon Health's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Agilon Health (AGL), the current Buyback Yield % is 0.16 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Agilon Health (AGL) Overvalued in 2026?
Based on GuruFocus' analysis, Agilon Health stock appears to be overvalued.
The current stock price of $111.79 is trading 18.4% above its estimated GF Value™ of $94.38.
GuruFocus considers Agilon Health to be Modestly Overvalued.
Key valuation signals for AGL:
Buyback Yield %: 0.16
GF Value™: $94.38 vs. price of $111.79 (18.4% above fair value)
No single metric tells the full story. See the AGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
74GF Score
Get the complete analysis for AGL
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AGL has been successfully added to your 
